|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | SLICC/ ACR damage index is valid and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus显示文摘 | Seifert B Isenberg DA | 1996 | Br J Rheumatol1996，35，2： | 1 |
| 2 | A developer's guide to silhouette algorithms for polygonal models显示文摘 | Isenberg T Freudenberg B Halper N | 2003 | IEEE Computer Graphics and Applications2003，23，4： | 1 |
| 3 | Maintenance ECT:indications and outcome显示文摘 | Schwarz T Loewenstein J Isenberg KE | 1995 | Convuls Ther1995，11，1： | 1 |
| 4 | The chemical biology of nitric oxide: Implications in cellu- lar signaling显示文摘 | Douglas D T Ridnour L A Isenberg J S | 2008 | Free Radical Biol Med2008，45，1： | 1 |
| 5 | A developer's guide to silhouette algorithms for polygonal models显示文摘 | ISENBERG T FREUDENBERG B HALPERN | 2003 | IEEE Computer Graphics Applications2003，23，4： | 1 |
| 6 | Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus:Is there a role for antiphospholipid antibodies?显示文摘 | MOK M Y FAREWELL V T ISENBERG D A | 2000 | Ann Rheum Dis2000，59，6： | 1 |
| 7 | Immunoelectrophoresis and ELISA techniques for assay of plasma β2-glycoprotein I and the influence of plasma lipids 显示文摘 | McNally T Mackie I J Isenberg D A | 1993 | Thrombosis Research1993，72，4： | 1 |
| 8 | Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation triaI显示文摘 | Choy EH Isenberg DA Garrood T | 2002 | Arthritis Rheum2002，46，12： | 1 |
| 9 | Assessment of a lupus nephritis cohort over a 30-year period显示文摘 | Croca SC Rodrigues T Isenberg DA | | 0，，： | 1 |
| 10 | A developer's guide to silhouette algorithms for polygonal models显示文摘 | Isenberg T Freudenbert B Halper N | 2003 | IEEE Computer Graphics and Applications2003，，4： | 1 |
| 11 | Therapeuticbenefit of blocking interleukin-6 activity w ith an anti-in-terleukin-6 receptor monoclonal antibody in rheumatoidarthritis:a randomized,doubleblind,placebo-con-trolled,dose-escalation trial显示文摘 | Choy E H Isenberg D A Garrood T | 2002 | Arthritis Rheum2002，46，12： | 1 |
| 12 | SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus 显示文摘 | Stoll T Seifert B Isenberg DA | 1996 | British Journal of Rheumatology1996，35，： | 1 |
| 13 | A Developer's Guide to Silhouette Algorithms for Polygonal Models 显示文摘 | Isenberg T Freudenberg B Halper N | 2003 | IEEE Computer Graphics and Applications2003，，4： | 1 |
| 14 | Rotenoen reversal of WY-14643-induced inhibition of hepatic gap junctional communication显示文摘 | Kamendulis L M Isenberg J S Prow T W | 1997 | Fund Appl Toxicol1997，36，： | 1 |
| 15 | A developers' guide to silhouette algorithms for polygonal models 显示文摘 | ISENBERG T FREUDENBERG B HALPER N | 2003 | Computer Graphics and Applications2003，23，4： | 1 |
| 16 | Fabrication of a layered microstructured polycaprolactone construct for 3-D tissue engineering显示文摘 | Sarkar S Isenberg B C Hodis E Leach J B Desai T A Wong J Y | 2008 | J Biomater Sci Polym Ed2008，19，： | 1 |
| 17 | Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalafion trial显示文摘 | Choy E H Isenberg D A Garrood T | 2002 | Arthritis Rheum2002，46，12： | 1 |
| 18 | Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis:a randomized,double-blind,placebo-controlled,dose-escalation trial显示文摘 | Choy EHl Isenberg DA Garrood T | 2002 | Arthritis Rheum2002，46，12： | 1 |
| 19 | Fast pyrolysis of coconut biomass: An FTIR study显示文摘 | Siengchum T Isenberg M Chuang S S C | 2013 | Fuel2013，105，： | 1 |
| 20 | Conjunctival anaerobic and aerobic bacterial flora in paediatric versus adult subjects 显示文摘 | Singer T R Isenberg S J Apt L | 1988 | Br J Ophthaltool1988，72，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员